CanVasc

CanVasc is a non-profit Canadian network of physicians and scientists with a clinical and research interest in systemic vasculitis.

[CanVasc @can_vasc]

🚨 Don't miss the next CanVasc webinar! 🚨
🏛️Topic: Update from the American College of Rheumatology Convergence 2024
🕖 Tuesday, December 3rd, 7:00-8:00pm EST

Register here: https://t.co/GryMs6m9Xt

#CanVasc #MedicalEducation #Healthcare #WebinarAlert

[CanVasc @can_vasc]

#ANCA and #ILD
Up to 10% of patients with ILD have positive ANCAs, and many have other concomitant auto-antibodies.

https://t.co/Vf8ADsu7CB

[CanVasc @can_vasc]

For those interested @CRASCRRheum, it's free!

[CanVasc @can_vasc]

If you missed our May webinary "Tools for Improving the Diagnosis of GCA" with Dr. JP Makhzoum, DR. Junek and Dr. Seidman, no problem! You can view it (along with our other webinars) online now on the CanVasc Website: https://t.co/ZjSh33qYgk

[CanVasc @can_vasc]

Vasculitis Seminar May 3, 2024 @ Sacre-Coeur Hospital, Montral. For more information and registration: https://t.co/wIfvecYF48

[CanVasc @can_vasc]

Save the date! Upcoming CanVasc Webinar: "Tools for Improving the Diagnosis of GCA" with Dr. JP Makhzoum, Dr. M Junek, & Dr. N Seidman. May 27, 2024 7:00-8:00pm EDT. Registration coming soon on the CanVasc website...

[CanVasc @can_vasc]

Who else is in Barcelona? Looking forward to a great week!

[CanVasc @can_vasc]

Come join us in Barcelona for the 21st International Vasculitis Workshop. Early registration is Jan 15, 2024. Register today! https://t.co/pY2xTisSkZ.

[CanVasc @can_vasc]

Please join us on Dec 14, 2023 7:00-8:00 EST for the last of the 2023 webinars: "Vasculitis Updates from ACR and the ASN" with Dr. B Barr, Dr. S Garner, and Dr. L Barra.
REGISTER HERE: https://t.co/iGrrxsLIJl

[CanVasc @can_vasc]

CanVasc LVV Working Group Fall Meeting - Let us know your availability. Email Stephanie Garner to suggest items for the agenda. https://t.co/3lgCOgJzfZ

[CanVasc @can_vasc]

New review article by CanVasc members on ILD in patients with ANCA-associated vasculitis. Check it out! https://t.co/4mCVaurYlB

[Eduardo Martín-Nares @drlalonares]

👆🏼#VEXAS syndrome is believed to only affect individuals above the age of 50.

😮We describe an early-onset case in a 23 y/o 🙎🏽‍♂️ with relapsing polychondritis.

🗝️Test for UBA1 mutations🧬, regardless of age, in adults with a VEXAS clinical phenotype.

@ivette_pataki @RheumJnl

[CanVasc @can_vasc]

Recent study by the FVSG looking at benralizumab in EGPA: https://t.co/1PbgEBgq7K

[CanVasc @can_vasc]

2-year follow-up data from the LoVAS trial is now available: https://t.co/G8QS0ewOAi

[CanVasc @can_vasc]

New study looking at the potential role of dupilumab in treating EGPA : https://t.co/eoW5lUlNN7

[CanVasc @can_vasc]

Calgary Vasculitis Symposium is coming up on October 12, 2023! Who's going? Register here:
https://t.co/ptJxUCb4kc

[CanVasc @can_vasc]

Canadian Study - Using a combination of clinical score and CDUS halo count can provide an accurate GCA prediction method for GCA Fast-Track clinics. https://t.co/uKg298OUzC

[CanVasc @can_vasc]

Attention CanVasc members: Please complete this survey to help us understand granulomas in ANCA associated vasculitis - https://t.co/fvy2HaCzny

[CanVasc @can_vasc]

Another publication by one of our CanVasc members: https://t.co/P9PTnI0JJw

[CanVasc @can_vasc]

Ocular manifestations are common in AAV, especially GPA according to this retrospective study published by our very own CanVasc members. Check it out: https://t.co/PdP1fy0y0N